Echo IQ (ASX:EIQ) Receives $1.26M R&D Tax Incentive
Echo IQ (ASX:EIQ) secures $1.26 million R&D Tax Incentive for AI-driven cardiac technology development.
Echo IQ (ASX:EIQ) secures $1.26 million R&D Tax Incentive for AI-driven cardiac technology development.
Osteopore Limited (ASX:OSX) announces a $20 million convertible notes offering to fund business expansion and future projects.
Artrya Limited (ASX:AYA) suspends trading ahead of a major software license and capital raising announcement.
Wellnex Life Limited (ASX:WNX) has initiated a trading halt pending a material capital raising announcement related to its UK LSE AIM listing.
Vitura Health Limited (ASX:VIT) acquires Candor Medical, enhancing its specialty healthcare services and boosting EBITDA.
EMVision Medical Devices (ASX:EMV) receives US IRB approval for pivotal trial of the emuâ„¢ brain scanner, maintaining progress towards March 2025 activation.
Clarity Pharmaceuticals (ASX:CU6) enhances its breast cancer pipeline with new radiopharmaceutical and secures critical supply agreement.
Ramsay Health Care (ASX:RHC) announces two non-recurring items impacting its 1H FY25 financial results, including UK segment impairment and tax provision release.
Alterity Therapeutics (ASX:ATH) secures A$40 million to advance ATH434 development for Parkinsonian disorders, supported by institutional investors.
Careteq Limited (ASX:CTQ) forms a strategic partnership with MedicAlert Foundation Australia to enhance medication safety for Australians.